Generation of Human Primordial Germ Cell-like Cells at the Surface of Embryoid Bodies from Primed-pluripotency Induced Pluripotent Stem Cells

Overview

This article presents a method for generating human primordial germ cell-like cells (PGCLCs) from primed pluripotency induced pluripotent stem cells (iPSCs) within a 13-day protocol. The technique aims to advance research in human germline toxicology by enabling the study of genomic integrity in PGCs.

Key Study Components

Area of Science

• Neuroscience
• Stem Cell Biology
• Germline Toxicology

Background

• Primordial germ cells (PGCs) are precursors to sperm and eggs.
• Human embryonic PGCs are derived from pluripotent epiblast cells.
• Understanding PGCs is crucial for insights into germline health.
• This study focuses on generating PGCLCs from iPSCs with disease predisposition.

Purpose of Study

• To develop a reliable method for generating human PGCLCs.
• To investigate the effects of genomic damage and repair in PGCs.
• To reduce germline toxicity associated with therapeutic drugs.

Methods Used

• Preparation of extracellular matrix protein-coated plates.
• Inoculation of primed pluripotency iPSCs into culture plates.
• Conversion of iPSCs to naive pluripotent stem cells.
• Formation and maintenance of embryoid bodies (EBs) in culture.

Main Results

• Successful generation of PGCLCs from primed iPSCs within 13 days.
• High cell density and accurate medium changes were critical for success.
• PGCLCs were identified as OCT4-positive cells.
• Method allows for the study of germline toxicity in a controlled environment.

Conclusions

• This protocol provides a valuable tool for studying human germline biology.
• It has implications for understanding and preventing genomic impairment.
• The method can facilitate research into germline toxicology and drug safety.

Frequently Asked Questions